Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hämeenlinna Metabolic Syndrome Research Program (HMS): Surrogate Indicators for Atherosclerosis in Men With Metabolic Syndrome, Coronary Heart Disease and Controls

NCT01119404 is registered in ClinicalTrials.gov with Kanta-Häme Central Hospital as lead sponsor.

NCT NCT01119404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01119404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hämeenlinna Metabolic Syndrome Research Program (HMS): Surrogate Indicators for Atherosclerosis in Men With Metabolic Syndrome, Coronary Heart Disease and Controls
Lead sponsor
Kanta-Häme Central Hospital
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2003
Completion date
December 31, 2014
Enrollment
300 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

coronary heart disease, metabolic syndrome